Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
This report updates the 2016–17 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines (MMWR Recomm Rep 2016;65[No. RR-5]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. A licensed, recommended, and age-appropriate vaccine should be used.
Anaphylaxis is a life-threatening allergic reaction. Summertime is riddled with potential suspects: fire ants, bees, foods, medications. See our WINK News video for more information:
Click to set custom HTML
Please read "News" drop down section of "What to know" for important information regarding the drifted influenza virus.
Read interesting article by Jane Brody on non-celiac gluten sensitivity (NCGS) appearing in the Personal Health section of New York Times:
Visit the following interactive site for information regarding the flu: http://www.cdc.gov/flu/
Review the CDC's influenza general information page titled, "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season". If your child has a history of egg allergy, review the algorithm enclosed. Otherwise, consider vaccinating yourself and your loved ones this year. Our practice will offer very limited supplies of the influenza vaccine, and will begin vaccinations the week of September 22nd.
One of the most rewarding aspects of working as a physician involves making a positive difference in someone's life. Many thanks to the Charlotte Sun readers for voting our practice 2014 Best Allergist, an honor for the 13th year in a row!
Board certification in allergy and immunology sub-specialty care had been the Gold Standard in defining quality medical care. The lines have been blurred the last two to three years as Board-certified allergists face new challenges in their daily practice. I applaud the Asthma & Allergy Network, Mothers of Asthmatics (AANMA) for their selfless battle against unscrupulous "allergy" organizations offering "expert" allergy care to clueless patients. For further information, visit one of the following reputable sites:
AANMA at http://www.aanma.org/2014/04/deception-and-fraud-in-allergy-care/ ,
The American College of Allergy, Asthma & Immunology (ACAAI) at
and The American Board of Medical Specialties (ABMS) at http://www.abms.org/About_Board_Certification/means.aspx
An additional treatment option for some allergy sufferers will soon be made available by your allergist.The FDA has approved two sublingual allergy immunotherapy tablets: grass allergy tablet, GRASTEK, was approved in early part of this month, and RAGWITEK, a sublingual allergy tablet for ragweed pollen, was approved on April 17. House dust mite allergy tablets are expected to be approved by the FDA sometime next year. Although most patients seen in an allergist's office (and by primary care physicians) have numerous environmental allergens triggering allergy symptoms, this alternative therapy will be an option for those with single allergens (grass, ragweed, or house dust mites). Further information will be available during your office consultation.
Dr. Elvin Mendez
Dr. Elvin M. Mendez is a Board-Certified Allergist & Immunologist in private practice in Port Charlotte, Florida.